Antidepressant Response in Major Depressive Disorder: A Meta-Regression Comparison of Randomized Controlled Trials and Observational Studies

被引:50
作者
Naudet, Florian [1 ,2 ,3 ]
Maria, Anne Solene [1 ,4 ]
Falissard, Bruno [1 ,5 ,6 ,7 ]
机构
[1] Inst Natl Sante & Rech Med, U669, Paris, France
[2] Univ Rennes 1, Unite Rech Univ Behav & Basal Ganglia EM 425, Rennes, France
[3] Univ Psychiatrie, Serv Hosp, Ctr Hosp Guillaume Regnier, Rennes, France
[4] Ecole Psychol Praticiens, Paris, France
[5] Univ Paris Sud, Paris, France
[6] Univ Paris 05, Unite Mixte Rech S0669, Paris, France
[7] Hop Paul Brousse, Assistance Publ Hop Paris, Dept Sante Publ, Villejuif, France
来源
PLOS ONE | 2011年 / 6卷 / 06期
关键词
PLACEBO-RESPONSE; EFFICACY TRIALS; PRIMARY-CARE; DOUBLE-BLIND; METAANALYSIS; COEFFICIENTS; SEVERITY; BENEFITS; CRITERIA;
D O I
10.1371/journal.pone.0020811
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: To compare response to antidepressants between randomized controlled trials (RCTs) and observational trials. Methods and Findings: Published and unpublished studies (from 1989 to 2009) were searched for by 2 reviewers on Medline, the Cochrane library, Embase, clinicaltrials. gov, Current Controlled Trial, bibliographies and by mailing key organisations and researchers. RCTs and observational studies on fluoxetine or venlafaxine in first-line treatment for major depressive disorder reported in English, French or Spanish language were included in the main analysis. Studies including patients from a wider spectrum of depressive disorders (anxious depression, minor depressive episode, dysthymia) were added in a second analysis. The main outcome was the pre-/post-treatment difference on depression scales standardised to 100 (17-item or 21-item Hamilton Rating Scale for Depression or Montgomery and Asberg Rating Scale) in each study arm. A meta-regression was conducted to adjust the comparison between observational studies and RCTs on treatment type, study characteristics and average patient characteristics. 12 observational studies and 109 RCTs involving 6757 and 11035 patients in 12 and 149 arms were included in the main analysis. Meta-regression showed that the standardised treatment response in RCTs is greater by a magnitude of 4.59 (2.61 to 6.56). Study characteristics were related to standardised treatment response, positively (study duration, number of follow-up assessments, outpatients versus inpatients, per protocol analysis versus intention to treat analysis) or negatively (blinded design, placebo design). At patient level, response increased with baseline severity and decreased with age. Results of the second analysis were consistent with this. Conclusions: Response to antidepressants is greater in RCTs than in observational studies. Observational studies should be considered as a necessary complement to RCTs.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Effect of Psychobiotics on Psychometric Tests and Inflammatory Markers in Major Depressive Disorder: Meta-Analysis of Randomized Controlled Trials with Meta-Regression
    Misera, Agata
    Liskiewicz, Pawel
    Loniewski, Igor
    Skonieczna-Zydecka, Karolina
    Samochowiec, Jerzy
    PHARMACEUTICALS, 2021, 14 (10)
  • [2] Placebo and nocebo reactions in randomized trials of pharmacological treatments for persistent depressive disorder. A meta-regression analysis
    Meister, Ramona
    Jansen, Alessa
    Haerter, Martin
    Nestoriuc, Yvonne
    Kriston, Levente
    JOURNAL OF AFFECTIVE DISORDERS, 2017, 215 : 288 - 298
  • [3] The dose-effect association between acupuncture sessions and its effects on major depressive disorder: A meta-regression of randomized controlled trials
    Xu, Guixing
    Lei, Hanzhou
    Huang, Liuyang
    Xiao, Qiwei
    Huang, Biqing
    Zhou, Zhuo
    Tian, Hao
    Huang, Fengyuan
    Liu, Yilin
    Zhao, Ling
    Li, Xiang
    Liang, Fanrong
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 310 : 318 - 327
  • [4] Specificity profile of paroxetine in major depressive disorder: Meta-regression of double-blind, randomized clinical trials
    Serretti, Alessandro
    Gibiino, Sara
    Drago, Antonio
    JOURNAL OF AFFECTIVE DISORDERS, 2011, 132 (1-2) : 14 - 25
  • [5] Placebo Response in Randomized Controlled Trials of Antidepressants for Pediatric Major Depressive Disorder
    Bridge, Jeffrey A.
    Birmaher, Boris
    Iyengar, Satish
    Barbe, Remy P.
    Brent, David A.
    AMERICAN JOURNAL OF PSYCHIATRY, 2009, 166 (01) : 42 - 49
  • [6] Nocebo Response in Attention Deficit Hyperactivity Disorder: Meta-Analysis and Meta-Regression of 105 Randomized Clinical Trials
    Ramirez-Saco, David
    Barcheni, Maghie
    Cunill, Ruth
    Saez, Marc
    Farre, Magi
    Castells, Xavier
    JOURNAL OF ATTENTION DISORDERS, 2022, 26 (11) : 1412 - 1421
  • [7] Adjunctive ketamine and electroconvulsive therapy for major depressive disorder: A meta-analysis of randomized controlled trials
    Zheng, Wei
    Li, Xiao-Hong
    Zhu, Xiao-Min
    Cai, Dong-Bin
    Yang, Xin-Hu
    Ungvari, Gabor S.
    Ng, Chee H.
    Ning, Yu-Ping
    Hu, Yong-Dong
    He, Shu-Hua
    Wang, Gang
    Xiang, Yu-Tao
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 250 : 123 - 131
  • [8] A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults
    Thase, Michael E.
    Mahableshwarkar, Atul R.
    Dragheim, Marianne
    Loft, Henrik
    Vieta, Eduard
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (06) : 979 - 993
  • [9] Efficacy and tolerability of esmethadone in patients with major depressive disorder: A meta-analysis of 3 randomized controlled trials
    Zhang, Lanlan
    Bao, Daocheng
    Wang, Chengzhong
    PSYCHIATRY RESEARCH, 2025, 348
  • [10] Esketamine Nasal Spray in Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials
    Wang, Zhibin
    Jiang, Lili
    Ma, Wenzhuang
    Li, Xingyue
    Gao, Qiushi
    Lian, Siyu
    Yu, Weiwei
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025,